51
Participants
Start Date
September 2, 2024
Primary Completion Date
October 29, 2025
Study Completion Date
October 29, 2025
Aflibercept (BAY86-5321, Eylea)
8 mg, intravitreal injection
Budapesti Bajcsy-Zsilinszky Korhaz es Rendelointezet, Budapest
Semmelweis Egyetem, Budapest
Budapest Retina Associates, Budapest
Debreceni Egyetem Klinikai Kozpont, Debrecen
Fakultní nemocnice Královské Vinohrady - Urologická klinikay, Prague
Axon Clinical, s.r.o., Prague
Univerzitna nemocnica Bratislava, Nem. Sv. Cyrila a Metoda, Bratislava
Fakultna nemocnica s poliklinikou Zilina, Žilina
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Bayer
INDUSTRY